Hemispherx Biopharma Inc. has made an agreement with Emerge Health Pty Ltd. to seek approval of Alferon N Injection in Australia and New Zealand and to commence distribution of Alferon in both countries on a named-patient basis, where deemed appropriate. Hemispherx and Emerge will collaborate on seeking regulatory approval from Australia’s Therapeutic Goods Administration (TGA) and New Zealand’s Medicines and Medical Devices Safety Authority (Medsafe). Under an exclusive licens...